eCARTv5 Clinical Deterioration Suite (“eCART”) vs OneDash

AgileMD's eCART is praised by users for its intuitive user interface and seamless integration with existing EHR systems, which minimizes disruption and streamlines workflows. This integration is highlighted as superior to standalone tools, suggesting a better overall user experience for clinicians. OneDash's usability information is less detailed, though it does offer a mobile app and a user guide for clinicians and administrators.

AgileMD's eCARTv5 is an FDA-cleared Software as a Medical Device (SaMD) that has undergone extensive multicenter retrospective and prospective validation, demonstrating high accuracy in predicting clinical deterioration (death or ICU transfer) across various patient populations and conditions. It leverages up to 97 real-time variables from EHRs and provides embedded clinical pathways for care guidance. OneDash focuses on identifying high-risk patients and automating care gap closure, integrating social determinants of health, but lacks FDA clearance and detailed public clinical validation studies.

Both tools require contacting the vendor for a tailored quote, indicating a lack of public pricing transparency. AgileMD's pricing is noted to be custom and potentially per-user or monthly. OneDash has a starting price of $19 per user per month for certain features, which is on the higher end compared to some alternatives, but its overall value proposition would depend on the specific features and scale of deployment. Without specific quotes for comparable scopes, it's difficult to definitively declare a winner in terms of pricing and value.

AgileMD's eCART is deployed as a cloud-based SaaS solution that integrates directly into EHR systems like Epic and Cerner, and is used in over 400 hospitals by more than 150,000 clinical users, processing millions of patient encounters. It is SOC-II and HIPAA compliant, and its rapid, seamless implementation in days to weeks further supports its enterprise readiness. While OneDash is also cloud-based and offers data export, the scale of its enterprise adoption and specific integration capabilities are not as extensively detailed.

AgileMD's eCARTv5 utilizes a gradient-boosted machine learning model for continuous, all-cause clinical deterioration prediction, which has been rigorously validated and received FDA clearance. This focus on early warning systems with high accuracy and low false alarms, coupled with embedded clinical pathways, represents significant innovation in proactive patient care. OneDash's innovation lies in unifying diverse data sources, including social determinants of health, for automated care gap closure and quality measure improvement, which is valuable but not as distinctly differentiated in the AI/ML model itself compared to eCARTv5's clinical prediction capabilities.

AgileMD offers various resources including an engineering blog and multiple developer resources, along with support and system status information. User reviews also highlight strong support. OneDash provides a user guide with documentation for clinicians, admins, and pharmacy operators, covering various features and offering support via email. However, AgileMD's broader range of publicly available resources and positive user feedback on support suggest a more comprehensive offering.